30 participants
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-27
- Start Date:
- 2026-05-14
- Completion:
- 2029-05-14
Conditions
- Acute Myeloid Leukemia (AML)
Interventions
- BIOLOGICAL
- DRUG
No Results Yet